Ballard Spahr LLP
Bacteriophage or lytic protein derived from the bacteriophage which effective for the treatment of Staphylococcus aureus biofilm
The present invention relates to compositions for removing a biofilm formed by Staphylococcus aureus, comprising a bacteriophage, such as Myoviridae family T4-like phage genus bacteriophage (Accession No: KCTC 11153BP, SAP-1) or Podoviridae family φ29-like virus genus bacteriophage (Accession No: KCTC11154BP, SAP-2), and lytic protein derived therefrom, that destroys the biofilm. Also disclosed are pharmaceutical compositions for the treatment of diseases caused by Staphylococcus aureus capable of forming biofilm.
iNtRON Biotechnology, Inc.
C C A A A A A
C12N C12N A01N A01N A61K A61P A61K
additional additional inventional inventional additional inventional inventional
Jeesoo Seongjun Sooyoun Se Yung Yunjaie Sanghyeon
Son Yoon Jun Lee Choi Kang